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Background: A part of the prospective, multi-institutional National Vet-
erans Affairs Surgical Quality Improvement Program was developed to
predict 30-day mortality and morbidity for patients undergoing a major
pulmonary resection. Methods: Perioperative data were acquired from
194,319 noncardiac surgical operations at 123 Veterans Affairs Medical
Centers between October 1, 1991, and August 31, 1995. Current Pro-
cedural Terminology code-based analysis was undertaken for major pul-
monary resections (lobectomy and pneumonectomy). Preoperative,
intraoperative, and outcome variables were collected. The 30-day mor-
tality and morbidity models were developed by means of multivariable
stepwise logistic regression with the preoperative and intraoperative
variables used as independent predictors of outcome. Results: A total of
3516 patients (mean age 64 ± 9 years) underwent either lobectomy (n =
2949) or pneumonectomy (n = 567). Thirty-day mortality was 4.0% for
lobectomy (119/2949) and 11.5% for pneumonectomy (65/567). The pre-
operative predictors of 30-day mortality were albumin, do not resusci-
tate status, transfusion of more than 4 units, age, disseminated cancer,
impaired sensorium, prothrombin time more than 12 seconds, type of
operation, and dyspnea. When the intraoperative variables were consid-
ered, intraoperative blood loss was added to the preoperative model. In
the presence of these intraoperative variables in the model, do not resus-
citate status and prothrombin time more than 12 seconds were only
marginally significant. Thirty-day morbidity, defined as the presence of
1 or more of the 21 predefined complications, was 23.8% for lobectomy
(703/2949) and 25.7% for pneumonectomy (146/567). In multivariable
models, independent preoperative predictors (P < .05) of 30-day mor-
bidity were age, weight loss greater than 10% in the 6 months before
surgery, history of chronic obstructive pulmonary disease, transfusion
of more than 4 units, albumin, hemiplegia, smoking, and dyspnea. When
intraoperative variables were added to the preoperative model, the
duration of operation time and intraoperative transfusions were includ-
ed in the model and albumin became marginally significant. Conclusions:
This analysis identifies independent patient risk factors that are associ-
ated with 30-day mortality and morbidity for patients undergoing a
major pulmonary resection. This series provides an initial risk-adjust-
ment model for major pulmonary resections. Future refinements will
allow comparative assessment of surgical outcomes and quality of care
at many institutions. (J Thorac Cardiovasc Surg 1999;117:969-79)
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S everal single-institution, retrospective series havebeen published that examine patient characteristics
associated with an increased risk of mortality and mor-
bidity after major pulmonary resection. Because series
span several decades and are of limited size, multivari-
able analyses were not undertaken.1-12 The National
Veterans Affairs (VA) Surgical Quality Improvement
Program was designed to prospectively collect histori-
cal, laboratory, operative, and postoperative patient
characteristics and clinical outcomes for many opera-
tive procedures from several surgical subspecialties.
The goal of the study was to develop tools for future
risk-adjusted models of mortality and morbidity that
would allow for the comparative assessment of the
quality of surgical care at various institutions.13-18 This
project examined the subset of patients who had
undergone a major pulmonary resection (lobectomy or
pneumonectomy).
Methods
The methods of the National VA Surgical Quality Improve-
ment Program have been described in detail elsewhere.13
Population. Data were acquired prospectively on 194,319
consecutive patients undergoing noncardiac surgical proce-
dures from October 1, 1991, until August 31, 1995, in 123
Department of VA Medical Centers. The database included
10,008 patients who had undergone a lung operation, of
which 3516 (35%) were for a major pulmonary resection
(Current Procedural Terminology [CPT] codes 32440-32445
and 32480-32488). International Classification of Diseases—
ninth revision—Clinical Modification (ICD-9-CM) diag-
noses for these pulmonary resections included 3251 for can-
cer (non–small cell lung cancer = 3105, pulmonary metastatic
cancer = 146), 34 benign lung masses (hamartoma or typical
carcinoid), 156 infectious processes (Mycobacterium tuber-
culosis = 27, fungal = 36, bronchiectasis = 25, infectious mas-
sive hemoptysis = 19, inflammatory lung masses with pneu-
monia = 49), and 51 other lung masses (not otherwise stated).
Patient characteristics and clinical outcomes. A total of
122 separate variables were recorded for each operation by a
dedicated surgical nurse reviewer who was independent of the
various surgical teams, allowing unbiased data collection.
Each reviewer was educated on the set of standard criteria for
coding all collected variables. These variables were selected
by a committee of expert advisors to the VA National Surgical
Quality Improvement Program, and the data management
manual was made available on the Internet in late 1998. A
system of data audits was performed throughout the study
interval to ensure data quality and completeness. In brief,
after the data manager education process was completed,
each center underwent periodic internal and external random
audits for data quality. Whenever possible, data were directly
downloaded to the statistical center from each VA Medical
Center’s computer (ie, laboratory results). A more complete
description of the data collection and auditing process is
given in a manuscript presented at the 1998 meeting of the
American Surgical Association.14
Preoperative patient characteristics included 4 demograph-
ic, 43 historical (divided among anatomic systems), and 17
preoperative laboratory values. Thirteen intraoperative and
operation-specific variables were recorded. Follow-up 30-day
postoperative mortality statistics and the presence of any
one of 21 pre-defined postoperative complications occur-
ring within 30 days of the index operation were recorded
(Appendix 1).
Statistical analysis. Univariate analyses were performed
on the preoperative, demographic, and laboratory variables,
relating them to operative mortality and morbidity. In the case
of continuous variables, an unpaired t test was used. For the
categoric variables, a c 2 test was used. The variables with a
prevalence of greater than 0.5% that were univariately signif-
icant at P < .20 were considered as possible independent vari-
ables in a multivariable logistic regression. Stepwise logistic
regression analysis with entry and exit criteria set at the P =
.05 level was used with 30-day mortality as the dependent
variable. For morbidity, the presence or absence of one or
more complications was used as the dependent variable.
Subsequent mortality and morbidity models were devel-
oped to incorporate the type of operation (pneumonectomy or
lobectomy) and then the intraoperative variables such as
operation time and amount of blood loss. The modeling was
done in a 2-stage process. The first-stage model consisted of
preoperative variables and the type of operation. In the sec-
ond stage the variables from the preoperative model were
fixed and the intraoperative variables were added to these for
possible inclusion in the stage 2 model. The second-stage
model then consists of the first-stage model plus the intraop-
erative variables that were significant in the second model.
Variables in the models are listed in Appendix 2.
All data were more than 99% complete, including the pre-
operative laboratory variables, except for serum albumin
(78%), serum bilirubin (79%), alkaline phosphatase (77%),
and serum aspartate aminotransferase (75%). A regression pro-
cedure was used to impute missing laboratory values.19,20
Some of the laboratory variables were not linearly related to
the postoperative outcomes, but rather had U shapes or invert-
ed J shapes. In these cases, the categorized laboratory variables
based on clinical cutoff points were entered into the models.
To investigate the stability of the models, we used a boot-
strap technique.21,22 In the bootstrap procedure, repeated
samples of n observations are selected with replacement from
the original set of n observations. For each sample, forward
stepwise logistic regression was performed simultaneously
entering the preoperative and intraoperative variables listed in
Appendix 1. The stability of the final stepwise model can be
assessed by identifying the variables that enter most fre-
quently in the repeated bootstrap models and comparing
those variables with the variables in the final stepwise model.
If the final stepwise model variables occur in a majority
(>50%) of the bootstrap models, the original final stepwise
regression model can be judged to be stable.
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Results
Patient characteristics and outcomes. The popula-
tion for this project consisted of 3516 patients who
underwent either an anatomic lobectomy (n = 2949) or
a pneumonectomy (n = 567). The mean age for the
study sample is 64 years with a standard deviation of 9
years and a range from 22 to 91 years. The majority of
the population was male (98.7%). Other selected
patient characteristics are listed in Table I. There were
119 deaths within 30 days for the patients undergoing
lobectomy (4.0%) and 65 deaths for those undergoing
pneumonectomy (11.5%), for an overall 30-day mor-
tality of 5.2% in the 3516 patients. The postoperative
morbidity for the lobectomy patients was 23.8%
(703/2949) and for the pneumonectomy patients was
25.7% (146/567). The overall 30-day morbidity was
24.1% (849/3516). The most frequently occurring
complications were pneumonia (11.7% for lobectomy
and 9.7% for pneumonectomy) followed by unplanned
reintubation (7.9% and 10.6%). Other individual com-
plication rates are shown in Table II.
Univariate analyses. Patient characteristics associat-
ed with an increased risk of 30-day mortality (P < .2)
included 24 preoperative clinical, 9 laboratory, and 4
intraoperative variables. Patient characteristics associ-
ated with an increased risk of 30-day morbidity includ-
ed 24 preoperative, 9 laboratory, and 3 intraoperative
variables. Eighteen preoperative and 6 laboratory vari-
ables were commonly significant in the univariate
analyses for both mortality and morbidity.
Multivariable analyses. All factors with a preva-
lence of greater than 0.5% of the sample and a univari-
ate significance of P < .2 were placed into a multivari-
able stepwise logistic regression analysis to identify
risk factors associated with mortality and morbidity. In
the multivariable logistic regression model for mortali-
ty, the preoperative independent predictors (P < .05)
were serum albumin, do not resuscitate status before
the operation, transfusion of more than 4 units of red
blood cells before the operation, age, disseminated can-
cer (defined as a resection for a pulmonary metastasis
or for patients with clinical evidence of mediastinal
lymph nodes in non–small cell lung cancer), impaired
sensorium, prothrombin time of more than 12 seconds,
operation type, and dyspnea. The b coefficients for
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Table I. Frequency distribution of selected patient 
characteristics and preoperative risk factors among 3516
patients undergoing lobectomy and pneumonectomy
Variable No. %
Male sex 3471 98.7
Smoking during the 2 weeks before 1806 51.4
admission
Chronic obstructive pulmonary disease 1372 39.0
Hypertension requiring medication 1319 37.5
Moderate or severe dyspnea 1163 33.1
More than two alcoholic drinks per day 657 18.7
during the 2 weeks before admission
Diabetes mellitus requiring insulin 395 11.2
or oral agents
Weight loss > 10% in 6 months before 383 10.9
surgery
Previous PTCA or coronary bypass 365 10.4
Previous stroke or transient ischemic 338 9.6
attack
Below- or above-knee amputation 198 5.6
Long-term steroid use 139 4.0
Congestive heart failure 81 2.3
Drug addiction 80 2.3
Hemiplegia 39 1.1
Table II. Observed 30-day mortality and morbidity by
primary operative procedure
Lobectomy Pneumonectomy 
(n = 2949) (n = 567)
Variable No. % No. %
Thirty-day mortality 119 4.0 65 11.5
Thirty-day morbidity 703 23.8 146 25.7
(1 or more complications)
Respiratory complications
Pneumonia 344 11.7 55 9.7
Unplanned reintubation 234 7.9 60 10.6
Failure to wean more than 48 h 194 6.6 53 9.3
Pulmonary embolism 20 0.7 8 1.4
Cardiac complications
Pulmonary edema 91 3.1 39 6.9
Cardiac arrest with CPR 76 2.6 39 6.9
Myocardial infarction 24 0.8 5 0.9
Wound complications
Superficial wound infection 41 1.4 9 1.6
Deep wound infection 35 1.2 6 1.1
Wound dehiscence 8 0.3 5 0.9
CNS complications
Coma more than 24 h 19 0.6 6 1.1
Stroke with neurologic deficit 17 0.6 6 1.1
Cerebral vascular accident 14 0.5 5 0.9
Urinary tract complications
Urinary tract infection 77 2.6 9 1.6
Progressive renal insufficiency 31 1.0 10 1.8
Acute renal failure 20 0.7 8 1.4
Other complications
Bleeding requiring > 4 units 85 2.9 17 3.0
transfusion
Systemic sepsis 80 2.7 16 2.8
Ileus/bowel obstruction 49 1.7 6 1.1
Deep venous thrombosis 20 0.7 4 0.7
Graft/prosthesis failure 1 0.0 2 0.4
CPR, Cardiopulmonary resuscitation; CNS, central nervous system.
these variables along with their P values and associated
odds ratios are contained in Table III-a. When the intra-
operative variables are added for possible entry into
this logistic model for mortality, the combined model
contains the preoperative predictors and the intraopera-
tive blood loss. This combined model is described in
Table III-b.
In the multivariable morbidity model, the preoperative
predictors significant at the .05 level were age, weight
loss of more than 10%, history of chronic obstructive
pulmonary disease, transfusion of more than 4 units of
red blood cells, serum albumin, hemiplegia, smoking,
and dyspnea. Table IV-a contains the b coefficients, P
values, and odds ratios for this model. When the intra-
operative variables are added, the resultant combined
model includes the preoperative predictors with opera-
tion time and intraoperative red blood cell units trans-
fused. Table IV-b lists the result of this model.
Model validation. The predictive validity (discrimi-
nation) of the model was measured by means of the c-
index.23,24 The c-indexes for the mortality models were
0.729 for the preoperative model and 0.749 for the
model including the intraoperative variables. The c-
indexes for the respective morbidity models were 0.623
and 0.646. These indexes indicate a moderate level of
predictability. The model fit was measured with the
Hosmer-Lemeshow25 statistic. The Hosmer-Lemeshow
statistics for the mortality models were 4.74 (P = .79)
and 6.56 (P = .58). The corresponding Hosmer-
Lemeshow statistics for the morbidity models were 5.81
(P = .67) and 8.43 (P = .39). These Hosmer-Lemeshow
statistics show a good level of fit for each of the models.
In addition, the stability of the mortality and morbid-
ity models was verified with a bootstrap resampling
method.26,27 The bootstrap resampling technique was
performed on 200 random samples for both mortality
and morbidity with the use of the preoperative and
intraoperative variables that were univariately signifi-
cant. All the variables in the final mortality model were
included in a majority of the 200 bootstrap replications
except for dyspnea and prothrombin time. For morbid-
ity, all variables in the final model were included in at
least 50% of the bootstrap replications, except for
smoking and albumin (Table V).
Discussion
Purpose of study. Advances in surgery require
prospectively collected, accurate, and reliable outcome
data. The Department of VA Medical Centers is an
excellent place to create an outcome database, because
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Table III-a. Multivariable logistic regression model
of 30-day mortality (preoperative variables and type
of operation)
Variable b Coefficient SE P value OR
Intercept –2.1970 0.8726
Higher serum albumin –.6449 0.1537 .0001 0.525
(g/dL)
Do not resuscitate status 1.4606 0.4855 .0026 4.309
present
Preoperative transfusion 1.9398 0.5685 .0006 6.957
> 4 RBC units present
Older age (y) .0327 0.0099 .0010 1.033
Disseminated cancer .6959 0.2572 .0068 2.006
present
Impaired sensorium .9974 0.4050 .0138 2.711
present
Prothrombin time .3627 0.1593 .0228 1.437
> 12 s present
Dyspnea present .3359 0.1586 .0342 1.399
Pneumonectomy –1.1103 0.1700 .0001 3.035
operations (vs lobectomy)
–2 LOG likelihood = 1317.1
C-index = 0.729
Hosmer-Lemeshow statistic = 4.74 (P = .7851)
The present/absent dichotomous risk variables were all coded as 0 = absent,
1 = present in the logistic regression analysis. Type of operation was coded as
0 = lobectomy, 1 = pneumonectomy. SE, Standard error; OR, odds ratio; RBC,
red blood cell.
Table III-b. Multivariable logistic regression model
of 30-day mortality (preoperative variables, type of
operation, and intraoperative variables)
Variable b Coefficient SE P value OR
Intercept –3.2584 0.9073
Higher serum albumin –.5075 0.1592 .0014 0.602
(g/dL)
Do not resuscitate status 1.0205 0.5592 .0680 2.775
present
Preoperative transfusion 1.9731 0.5704 .0005 7.193
> 4 RBC units present
Older age (y) .0356 0.0100 .0004 1.036
Disseminated cancer .6848 0.2588 .0081 1.983
present
Impaired sensorium .9749 0.0452 .0161 2.651
present
Prothrombin time .3007 0.1619 .0633 1.351
> 12 s present
Dyspnea present .3176 0.1610 .0485 1.374
Pneumonectomy –.9978 0.1737 .0001 2.712
(vs lobectomy)
Intraoperative blood loss .0006 0.0001 .0001 1.001
(mL)
–2 LOG likelihood = 1286.3
C-index = 0.749
Hosmer-Lemeshow statistic = 6.56 (P = .5845)
The present/absent dichotomous risk variables were all coded as 0 = absent,
1 = present in the logistic regression analysis. Type of operation was coded as
0 = lobectomy, 1 = pneumonectomy. SE, Standard error; OR, odds ratio; RBC,
red blood cell.
of its nationally based patient population and easily
retrieved computerized patient data. The National VA
Surgical Quality Improvement Program was estab-
lished in 1991 as a model of a multi-institutional out-
comes study. Patient risk and postoperative data on
more than 300,000 operative encounters have been col-
lected, 184,319 of which were for noncardiac proce-
dures.13,15 Variable definitions and data collection were
standardized across surgical subspecialties so that
aggregate analyses would be possible. 
The purpose of this project was to use these data to
construct a model of preoperative patient risk for mor-
tality and morbidity within 30 days of major pul-
monary resections. Data collection was prospective and
recent (1991-1995), eliminating any temporal bias that
existed in previous single-institution reports that
spanned decades and may not reflect current clinical
practice. Because a dedicated surgical nurse reviewer
acquired all of the data prospectively, its reproducibili-
ty and accuracy were assured. Interpretive test results,
such as electrocardiography and spirometry, were not
included in this study.
The 30-day mortality and morbidity rates (5.2% and
24.1%, respectively) from this multi-institution series
are in the range of those published from single-institu-
tion retrospective series (mortality 3%-14%; morbidity
10%-25%).1-9 The largest pneumonectomy series (n =
244) from the Mayo Clinic reported 11% deaths and
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Table IV-a. Multivariable logistic regression model of
30-day morbidity (preoperative variables and type of
operation)
Variable b coefficient SE P value OR
Intercept –2.3979 0.4981
Older age (y) .0291 0.0050 .0001 1.030
Weight loss > 10% .4762 0.1209 .0001 1.610
present
History of COPD .2830 0.0847 .0008 1.327
present
Preoperative transfusion 1.7901 0.5254 .0007 5.990
> 4 RBC units present
Higher serum albumin –0.2710 0.0896 .0025 0.763
(g/dL)
Hemiplegia present .9233 0.3307 .0052 2.518
Smoking present .2114 0.0831 .0109 1.235
Dyspnea present .2386 0.0866 .0059 1.269
–2 LOG likelihood = 3754.5
C-index = 0.623
Hosmer-Lemeshow statistic = 5.81 (P = .6684)
The present/absent dichotomous risk variables were all coded as 0 = absent,
1 = present in the logistic regression analysis. SE, Standard error; OR, odds
ratio; COPD, chronic obstructive pulmonary disease; RBC, red blood cell.
Table IV-b. Multivariable logistic regression model of
30-day morbidity (preoperative variables, type of
operation, and intraoperative variables)
Variable b coefficient SE P value OR
Intercept –3.4339 0.5253
Older age (y) .0314 0.0051 .0001 1.032
Weight loss > 10% .4719 0.1223 .0001 1.603
present
History of COPD present .2621 0.0855 .0022 1.300
Preoperative transfusion 1.6634 0.5355 .0019 5.277
> 4 RBC units present
Higher serum albumin –0.1501 0.0929 .1062 0.861
(g/dL)
Hemiplegia present .9708 0.3326 .0035 2.640
Smoking present .2363 0.0840 .0049 1.267
Dyspnea present .2435 0.0875 .0054 1.276
Longer operation time (h) .1013 0.0270 .0002 1.107
Intraoperative RBC unit .2309 0.0449 .0001 1.260
transfusion
–2 LOG likelihood = 3698.3
C-index = 0.646
Hosmer-Lemeshow statistic = 8.43 (P = .3929)
The present/absent dichotomous risk variables were all coded as 0 = absent,
1 = present in the logistic regression analysis. SE, Standard error; OR, odds
ratio; COPD, chronic obstructive pulmonary disease; RBC, red blood cell.
Table V. Morbidity and mortality bootstrap results
Mortality bootstrap Morbidity bootstrap
Variable Frequency selected % Variable Frequency selected %
Age 200 100 Type of operation 200 100
Operation time 195 97.5 Age 185 92.5
Weight loss > 10% 190 95.0 Intraoperative blood loss 142 71.0
Intraoperative RBC unit transfusion 170 85.0 Disseminated cancer 134 67.0
History of COPD 164 82.0 Albumin 120 60.0
Transfusion > 4 units 160 80.0 Transfusion > 4 units 115 57.5
Hemiplegia 147 73.5 Impaired sensorium 108 54.0
Dyspnea 126 63.0 DNR 103 51.5
RBC, Red blood cell; COPD, chronic obstructive pulmonary disease; DNR, do not resuscitate.
24% major morbidity within 30 days. These procedures
were performed for cancer and infection.10 Deslauriers
and associates11 reported a series of 1076 patients from
several centers in Canada who had undergone elective
lobectomy or pneumonectomy for cancer from 1978
until 1984. They observed an overall 3.2% mortality
and a 19% morbidity rate, which are similar to our
overall mortality and morbidity rates.
Multi-institution, prospective data are available from
the Lung Cancer Study Group (1979-1981). Ginsberg
and colleagues12 reported a 2.6% mortality for a lobec-
tomy (n = 1058) and a 6.2% mortality for a pneu-
monectomy (n = 569) for cancer. Silvestri and col-
leagues28 published data from hospital discharges in the
state of South Carolina from 1991 until 1995. This
study observed a 30-day mortality of 11.8% for pneu-
monectomy and 3.0% for lobectomy performed by
board-certified thoracic surgeons. Both of these series
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Fig 1. Statistical nomograms were constructed with 95% confidence intervals to demonstrate the results. Top,
Probability of death for age in years. Bottom, Probability of a complication for patient by age. Note that risk
increases with age. 
included elective operations performed for cancer. Our
VA data included 3516 consecutive patients who under-
went a lobectomy or pneumonectomy for any cause,
elective or emergency. There were 19 emergency proce-
dures for infection or massive hemoptysis, and 11
urgent or emergency procedures were performed on
patients who had previously asked not to be resuscitat-
ed in the event of a cardiac arrest. Significant comor-
bidity is common in this veteran population, including
39% of patients with chronic obstructive lung disease,
33% with moderate or severe dyspnea, 19% with chron-
ic alcoholism, 11% with diabetes, and 10% with a his-
tory of a stroke or transient ischemic attack. These fac-
tors may explain the higher mortality rates observed in
this population of male veterans. In fact, if the mortali-
ty models for lobectomy and pneumonectomy were
The Journal of Thoracic and
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Fig 2. Statistical nomograms were constructed with 95% confidence intervals to demonstrate the results. Top,
Probability of death for serum albumin. Bottom, Probability of a complication for patient by serum albumin. Note
that risk decreases with improved nutritional status.
used to a define a “low risk” subset of patients (expect-
ed mortality ≤ 5.0%), observed mortality was actually
2.5% for lobectomy and 7.0% for pneumonectomy. 
Limitations of study. The study population is pre-
dominantly male. The 1997 cancer statistics demon-
strate that 40% of newly diagnosed cases of lung can-
cer occur in women.29 Clearly, the generalizability of
this VA study will need to be verified in a more hetero-
geneous population. Early efforts by the Society of
Thoracic Surgeons may accomplish this goal, and this
VA study can act as a model for future analytical risk
models. In an effort for data consistency and complete-
ness, only easily quantifiable data were included and no
subspecialty procedure-specific morbidity (ie, bron-
chopleural fistula instead of pneumonia) was collected,
allowing consistent data collection throughout the VA
system. Future studies are being designed to include
procedure-specific variable collection, such as exercise
oximetry, spirometry, and predicted postresection
forced expiratory volume in 1 second.
Clinical relevance of models. Two separate analyses
were undertaken after univariate analyses identified
potential variables associated with mortality and mor-
bidity. The first model consisted of preoperative vari-
ables that would be readily available to clinicians, as
well as the type of resection planned (lobectomy or
pneumonectomy). The mortality model demonstrated
the significance of patient age, pulmonary reserve (dys-
pnea class), level of cognition, nutritional status (serum
albumin), liver function (serum prothrombin time),
clinical cancer stage, and need for a pneumonectomy
on perioperative survival. If one added the intraopera-
tive variables to this model, only the operative blood
loss (a measure of the difficulty of the operation) added
independent prognostic information.
The morbidity models included different variables. In
addition to patient age, serum albumin, and dyspnea
class, preoperative smoking, weight loss, and hemiple-
gia were significant predictors of a complicated post-
operative course. Intraoperative variables that signifi-
cantly predicted a complication included operative time
and blood loss, both markers of a more difficult opera-
tion, whereas there was no difference in the risk of a
complication between the two procedures once the
model accounted for these other significant variables.
Figs 1 and 2 demonstrate the results of two continuous
variables (age in years and serum albumin level before
operation) on mortality and morbidity.
Conclusion 
This recent series of lobectomy and pneumonectomy
in the Department of VA Medical Centers demonstrates
the feasibility of a prospective, national, multicenter
perioperative study. The outcome results obtained were
consistent with those published in the literature. The
large size of the population allowed the creation and
validation of a risk-adjusted model for patient selection
for major pulmonary resections. Therefore, in addition
to the clinically relevant assessment of the patient’s
health, one can use the b coefficients of the significant
factors present in a specific patient to determine the
probability of an adverse event in that patient. This is
the largest data set of its type and therefore allowed con-
struction of the most predictive model to date. Future
prospective multicenter studies of patients undergoing
major pulmonary resections may include other variables
(ie, spirometry and exercise oximetry), thereby increas-
ing the overall predictive validity of the models.
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Appendix 1
National Surgical Quality Improvement Program
Program Worksheet
A. PREOPERATIVE INFORMATION
1. GENERAL
a. Diabetes mellitus
1. No
2. Oral
3. Insulin
b. Current smoker within 2 weeks before admission
1. Yes
2. No
c. Alcohol > 2 drinks/day within 2 weeks before 
admission
1. Yes
2. No
d. Drug addiction
1. Yes
2. No
e. Dyspnea
1. No
2. Minimal exertion
3. Rest
f. Do not resuscitate status—this admission
1. Yes
2. No
g. Functional status
1. Independent
2. Partially dependent
3. Total dependent
2. PULMONARY
a. Ventilator dependent > 48 hours
1. Yes
2. No
b. History of severe chronic obstructive pulmonary disease
1. Yes
2. No
c. Current pneumonia
1. Yes
2. No
3. HEPATOBILIARY
a. Hepatomegaly
1. Yes
2. No
b. Ascites
1. Yes
2. No
c. Esophageal varices
1. Yes
2. No
d. Active hepatitis
1. Yes
2. No
4. CARDIAC
a. History of myocardial infarction within past 6 months
1. Yes
2. No
b. Previous percutaneous transluminal coronary 
angioplasty
1. Yes
2. No
c. Previous operation with cardiopulmonary bypass
1. Yes
2. No
d. History of angina within month before the operation
1. Yes
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2. No
e. Congestive heart failure within 1 month before the 
operation
1. Yes
2. No
f. Hypertension requiring medication
1. Yes
2. No
5. RENAL
a. Acute renal failure (change in creatinine > 
2.0 mg/dL)
1. Yes
2. No
b. Currently requiring dialysis
1. Yes
2. No
6. VASCULAR
a. History of revascularization/amputation for 
peripheral vascular disease
1. Yes
2. No
b. Rest pain/gangrene
1. Yes
2. No
c. Absent peripheral pulses
1. Yes
2. No
7. CENTRAL NERVOUS SYSTEM
a. Impaired sensorium
1. Yes
2. No
b. Severe head trauma
1. Yes
2. No
c. History of coma
1. Yes
2. No
d. Quadriplegia
1. Yes
2. No
e. Paraplegia
1. Yes
2. No
f. Hemiplegia
1. Yes
2. No
g. History of transient ischemic attacks
1. Yes
2. No
h. Cerebrovascular accident residual neurologic deficit
1. Yes
2. No
i. Cerebrovascular accident/no neurologic deficit
1. Yes
2. No
j. Neuromuscular degenerative disease
1. Yes
2. No
k. Tumor involving the central nervous system
1. Yes
2. No
8. NUTRITIONAL/IMMUNE/OTHER
a. Disseminated cancer (stage IV)
1. Yes
2. No
b. Open wound or infection
1. Yes
2. No
c. Chronic steroid use
1. Yes
2. No
d. >10% loss of body weight within last 6 months
1. Yes
2. No
e. Bleeding disorders
1. Yes
2. No
f. Transfusion > 4 red blood cell units this admission
1. Yes
2. No
g. Number of prior operations this admission
B. OPERATIVE INFORMATION
1. Surgical specialty: (code)
2. Principal operation: (CPT code)
3. Other procedures: (CPT code)
4. Concomitant procedures: (code)
5. Postgraduate-year primary surgeon
6. Emergency case
a. Yes
b. No
7. Wound classification
a. Clean
b. Clean/contaminated
c. Contaminated
d. Infected
8. Redo
a. Yes
b. No
9. American Society of Anesthesiology class
10. Principal anesthesia technique
a. General
b. Spinal
c. Epidural
d. Regular/local
11. Time operation began (24-hour clock)_____
12. Intraoperative blood loss (mL) (minimal = 100)_____
13. Number of red blood cell units transfused_____
C. OUTCOME INFORMATION
1. Postoperative diagnosis (ICD-9-Code)
2. Length of postoperative hospital stay (days)_____
3. Thirty-day postoperative status
4. Date of death _____
978 Harpole et al The Journal of Thoracic and
Cardiovascular Surgery
May 1999
5. Return to operating room within 30 days after index 
procedure
a. Yes
b. No
6. Number of returns related to index procedure _____
7. CPT code _____
8. CPT code _____
9. CPT code _____
10. Number of returns unrelated to index procedure
11. CPT code _____
12. CPT code _____
13. CPT code _____
D. COMPLICATIONS (See Table II)
E. LABORATORY VALUES
1. Preoperative (nearest to operation date)
a. Sodium______ Month____ Day____ Year____
b. Potassium______ Month____ Day____ Year____
c. Glucose______ Month____ Day____ Year____
d. BUN______ Month____ Day____ Year____
e. Creatinine______ Month____ Day____ Year____
f. CK______ Month____ Day____ Year____
g. CK-MB______ Month____ Day____ Year____
h. Albumin ______ Month ____Day____Year____
i. Total bilirubin______Month____ Day____ Year____
j. ALT______ Month____ Day____ Year____
k. AST______ Month____ Day____ Year____
l. AP______ Month____ Day____ Year____
m. WBC______Month____ Day____ Year____
n. Hct______ Month____ Day____ Year____
o. Platelets______ Month____ Day____ Year____
p. PTT______ Month____ Day____ Year____
q. PT______ Month ____Day____Year____
2. Postoperative laboratory values (record highest and 
lowest levels)
a. Sodium______ Month____ Day____ Year____
b. Sodium______ Month____ Day____ Year____
c. Potassium______ Month____ Day____ Year____
d. Potassium______ Month____ Day____ Year____
e. Glucose______ Month____ Day____ Year____
f. Creatinine______ Month____ Day____ Year____
g. CK______ Month____ Day____ Year____
h. CK-MB______ Month____ Day____ Year____
i. Albumin______Month ____ Day____ Year____
j. Total bilirubin______Month____ Day____ Year____
k. WBC______Month____ Day____ Year____
l. Hct______ Month____ Day____ Year____
Where BUN is blood urea nitrogen, CK is creatine kinase, AP
is alkaline phosphatase, ALT is alanine aminotransferase,
AST is aspartate aminotransferase, WBC is white blood cell
count, Hct is hematocrit, PTT is partial thromboplastin time,
and PT is prothrombin time.
Appendix 2
List of variables used in mortality and/or morbidity model-
ing (univariate P < = .2 and prevalence ‡ = 0.5%)
Mortality and morbidity
DRUGAD Drug addiction
DYSP Dyspnea (no vs minimal exertion or at 
rest)
DNR Do not resuscitate status
FNSTATUS Functional status
HXCOPD History of severe chronic obstructive 
pulmonary disease
CPNEUMON Current pneumonia
HXCHF Congestive heart failure within 1 month
preceding surgery
HXPVD History of revascularization/amputation 
for peripheral vascular disease
ABPULSE Absent peripheral pulse
IMPSENS Impaired sensorium
HEMI Hemiplegia
CVANEURO Cerebrovascular accident/residual 
neurologic deficit
WTLOSS >10% loss in body weight within last 
6 months
BLEEDDIS Bleeding disorders
TRANSFUS Transfusion > 4 red blood cell units this 
admission
EMERGNCY Emergency case
ASACLAS American Society of Anesthesiology class
AGE Age
PRALBUM Serum albumin
PRSODM Sodium
PRBUN Blood urea nitrogen
PRALKPH Alkaline phosphatase
PRHCT Hematocrit
PRPTT Partial thromboplastin time
Mortality only
SEX Gender
ETOH Alcohol > 2 drinks/day within 2 weeks 
before admission
DISCANCR Disseminated cancer
STEROID Long-term steroid use
NOPER Number of returns related to index 
procedure
XSCORE Complexity score of operation
PRPTAS Potassium
PRSGOT Aspartate aminotransferase
PRPT Prothrombin time
Morbidity only
DIABETES Diabetes
SMOKE Current smoker within 2 weeks of 
admission
HYPERMED Hypertension requiring medication
HXTIA History of transient ischemic attack
CVANO Cerebrovascular accident/no neurologic 
deficit
WNDCLASS Wound classification
PRWBC White blood cell count
PRPLAT Platelet counts
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